Australia markets closed

PYC Therapeutics Limited (PYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0570-0.0030 (-5.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
35,146
35,146
24,031
14,004
-
Selling general and administrative
2,542
2,542
4,380
6,176
5,671
Total operating expenses
39,163
39,163
30,208
21,833
9,745
Operating income or loss
-39,163
-39,163
-30,208
-21,833
-9,745
Interest expense
27.288
27.288
32.595
38.822
-
Total other income/expenses net
15,752
15,752
15,922
3,133
62.5
Income before tax
-23,356
-23,356
-14,294
-18,630
-9,475
Income tax expense
0
0
0
0
-2,396
Income from continuing operations
-23,356
-23,356
-14,294
-18,630
-7,080
Net income
-22,789
-22,789
-13,863
-17,768
-6,822
Net income available to common shareholders
-22,789
-22,789
-13,863
-17,768
-6,822
Basic EPS
-
-
-0.00
-0.01
-0.00
Diluted EPS
-
-
-0.00
-0.01
-0.00
Basic average shares
-
-
3,180,926
3,091,647
2,641,766
Diluted average shares
-
-
3,180,926
3,091,647
2,641,766